Cargando…
The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma
Receptor tyrosine kinases-based autocrine loops largely contribute to activate the MAPK and PI3K/AKT pathways in melanoma. However, the molecular mechanisms involved in generating these autocrine loops are still largely unknown. In the present study, we examine the role of the transcription factor R...
Autores principales: | Boregowda, Rajeev K., Medina, Daniel J., Markert, Elke, Bryan, Michael A., Chen, Wenjin, Chen, Suzie, Rabkin, Anna, Vido, Michael J., Gunderson, Samuel I., Chekmareva, Marina, Foran, David J., Lasfar, Ahmed, Goydos, James S., Cohen-Solal, Karine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045426/ https://www.ncbi.nlm.nih.gov/pubmed/27102439 http://dx.doi.org/10.18632/oncotarget.8822 |
Ejemplares similares
-
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
por: Cohen-Solal, Karine A., et al.
Publicado: (2015) -
Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma
por: Abushahba, Walid, et al.
Publicado: (2012) -
Role of the G Protein-Coupled Receptor, mGlu(1), in Melanoma Development
por: Wangari-Talbot, Janet, et al.
Publicado: (2010) -
Interferon Lambda: A New Sword in Cancer Immunotherapy
por: Lasfar, Ahmed, et al.
Publicado: (2011) -
Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)